Human Magnetic Luminex Assay LXSAHM: R&D Systems

Human Magnetic Luminex Assay

(17 citations)
(2 Reviews)
  
  • Assay Type
    Bead-based multiplex assay for the Luminex® platform
  • Format
    1 x 96-well microplate and magnetic antibody-coated beads
  • Analytes Detected
    Please see table below.
  • Performance Validation
     
    Product Features

Magnetic Luminex Assays are the most flexible bead-based multiplex assays that we offer. They allow up to 50 user-defined target analytes to be simultaneously profiled using cell culture supernates, serum, or plasma samples.

Features
  • User defines up to 50 analytes of interest
  • Wide selection of analytes
  • Requires a small sample volume (50 µL)
  • Mass-calibrated standards for consistent results with every new lot of material
  • Enough reagents for one 96-well plate
  • Quick turn-around time: Kits are typically shipped within 4-7 days of ordering.*

*Please allow additional time when placing orders through a distributor.

 

Kit Contents
  • Premixed antibody-coated magnetic bead cocktail
  • Premixed biotinylated detection antibody cocktail
  • Standard Cocktail(s)
  • Bead Diluent
  • Biotin Antibody Diluent
  • Standard/Sample Diluent
  • Wash Buffer
  • Streptavidin-PE
  • One Flat-bottom 96-well Microplate
  • Foil Plate Sealers
  • Mixing Bottle
  • Certificate of Analysis

 

Available Luminex Assays Analytes

The following chart indicates the bead region, sensitivity, high standard value, and recommended samples and their starting dilution for each analyte.

Analyte Sensitivity
(MDD)pg/mL
Standard
Curve Range (pg/mL)
Starting Sample Dilution Magnetic
Bead
Region
Cell Culture
Supernates
Serum Plasma
4-1BB/CD137 2.8 35.8-8,710 1:2 1:2 1:2 13
ADAMTS13 1,270 18,646-4,530,860 1:2 1:2 1:2 52
Adiponectin/Acrp30 148 842-204,700 1:2 1:200 1:200 44
Aggrecan 249 292-70,890 1:2 1:2 1:2 75
AgRP/ART 0.183 5.97-1,450 1:2 1:2 1:2 42
alpha-Fetoprotein 205 724-175,950 1:2 1:2 1:2 66
ALDH1A1 7.10 118-28,560 1:2 1:50 1:50 14
alpha 1-Microglobulin 29,563 147,826-35,921,600 1:2 1:2 1:2 15
Angiogenin 3.17 22.7-5,510 1:2 1:200 1:200 66
Angiopoietin-1 9.43 114-27,610 1:2 1:50 1:2 64
Angiopoietin-2 17.1 90.5-22,000 1:2 1:2 1:2 26
Angiopoietin-like 3 23.0 236-57,290 1:2 1:2 1:2 72
Angiopoietin-like 4 86.0 1,804-438,380 1:2 1:2 1:2 73
Angiopoietin-like 6, 12.0 296-71,930 1:2 1:2 1:2 12
ApoA1 1,502 21,432-5,207,920 1:2 1:4,000 1:4,000 13
APP 268 5,559-1,350,800 1:2 1:2 1:2 39
APRIL 7.95 202-49,200 1:2 1:2 1:2 43
B7-H1/PD-L1 56.5 114-27,790 1:2 1:2 1:2 14
beta 2-Microglobulin 17.2 75.2-18,270 1:2 1:4,000 1:4,000 13
BAFF/BLyS 1.01 17.4-2,360 1:2 1:2 1:2 44
BCMA 1.24 127-30,870 1:2 1:2 1:2 75
BDNF 0.320 16.2-3,940 1:2 1:50 1:2 15
BMP-2 3.6 24.6-5,980 1:2 1:2 1:2 67
BMP-4 5.0 49.7-12,080 1:2 1:2 1:2 72
BMP-7 8.56 104-25,220 1:2 1:2 1:2 30
BMP-9 0.6 5.0-1,220 1:2 1:2 1:2 73
BMP-10 1.6 13.4-3,250 1:2 1:2 1:2 29
CA125/MUC16 2.69 22.6-5,490 1:2 1:2 1:2 35
CA15-3 0.051 units/mL 0.177-43.0 units/mL 1:2 1:50 1:50 75
Calbindin D 12.3 30.5-7,400 1:2 1:2 1:2 33
Carbonic Anhydrase IX/CA9 2.11 9.71-2,360 1:2 1:2 1:2 45
Cardiac Myoglobin 1.26 16.3-3,970 1:2 1:50 1:50 42
Total Cathepsin S 9.65 126-30,710 1:2 1:2 1:2 35
CCL1/I-309 0.119 4.57-1,110 1:2 1:2 1:2 15
CCL2/MCP-1 9.9 31.9-7,740 1:2 1:2 1:2 25
CCL3/MIP-1 alpha 16.2 90.9-22,090 1:2 1:2 1:2 35
CCL4/MIP-1 beta 5.8 133.1-32,350 1:2 1:2 1:2 37
CCL5/RANTES 1.8 22.5-5,470 1:2 1:50 1:50 36
CCL7/MCP-3 3.15 35.3-8,570 1:2 1:2 1:2 37
CCL8/MCP-2 1.82 16.5-4,000 1:2 1:2 1:2 37
CCL11/Eotaxin 14.6 60.7-14,750 1:2 1:2 1:2 77
CCL13/MCP-4 0.42 6.5-1,570 1:2 1:2 1:2 38
CCL14/HCC-1/ HCC-3 31.8 147-35,610 1:2 1:50 1:50 28
CCL15/MIP-1 delta 134 869-211,080 1:2 1:2 1:2 36
CCL17/TARC 6.47 85.6-20,790 1:2 1:2 1:2 63
CCL18/PARC 0.326 11.4-2,760 1:2 1:50 1:50 33
CCL19/MIP-3 beta 0.765 11.1-2,690 1:2 1:2 1:2 42
CCL20/MIP-3 alpha 3.39 7.9-1,920 1:2 1:2 1:2 33
CCL21/6Ckine 9.06 35.4-8,600 1:2 1:2 1:2 65
CCL22/MDC 8.45 48.8-11,870 1:2 1:2 1:2 36
CCL24/Eotaxin-2/MPIF-2 1.34 21.2-5,160 1:2 1:2 1:2 34
CCL25/TECK 1.22 50.7-12,320 1:2 1:2 1:2 46
CCL26/Eotaxin-3 1.58 23.2-5,630 1:2 1:2 1:2 45
CCL27/CTACK 0.421 7.28-1,770 1:2 1:2 1:2 74
CCL28 3.76 148-35,890 1:2 1:2 1:2 43
CD14 39.6 202-49,180 1:2 1:200 1:200 29
CD23/Fc epsilon RII 16.5 167-40,550 1:2 1:2 1:2 44
CD27 4.84 117-28,330 1:2 1:2 1:2 67
CD30 0.130 1.9-470 1:2 1:2 1:2 61
CD31/PECAM-1 71.6 681-165,470 1:2 1:2 1:2 45
CD40 2.11 15.4-3,750 1:2 1:2 1:2 76
CD40 Ligand 34.7 212-51,430 1:2 1:2 1:2 74
CD44 42.6 110-26,700 1:2 1:2 1:2 72
CD117/c-kit/SCF R, NEW 93.5 755-183,370 1:2 1:2 1:2 19
CD163 530 5,196-1,262,520 1:2 1:2 1:2 28
CEACAM-1/CD66a, 158 2,007-487,620 1:2 1:2 1:2 54
CEA/CEACAM-5 12.9 168-40,850 1:2 1:2 1:2 30
Chemerin 69.0 369-89,710 1:2 1:2 1:2 67
Chitinase 3-like 1/YKL-40 3.3 352-85,610 1:2 1:2 1:2 20
Factor D/Adipsin 232 721-175,150 1:2 1:50 1:50 64
Factor XIV/ Protein C 23.1 199-48,440 1:2 1:50 1:50 36
Collagen I alpha 1/COL1A1 0.580 13.0-3,170 1:2 1:50 1:50 18
Collagen IV alpha 1 10.2 93-22,600 1:2 1:2 1:2 55
Contactin-1 3.58 230-55,890 1:2 1:2 1:2 48
C2 70.8 2,571-624,690 1:2 1:200 1:200 34
C3a 17.9 970-235,670 1:2 1:200 1:200 35
C5/C5a 0.210 844-205,000 1:2 1:2 1:2 18
C9 2,097 26,071-6,335,280 1:2 1:50 1:50 47
CRP 116 104-25,220 1:2 1:200 1:200 62
Cripto-1 14.3 38.1-9,260 1:2 1:2 1:2 19
CTRP9/C1qTNF9 0.75 11.6-2,810 1:2 1:2 1:2 33
CX3CL1/ Fractalkine 64.8 1,114-270,610 1:2 1:2 1:2 46
CXCL1/Gro alpha 5.3 151-12,200 1:2 1:2 1:2 77
CXCL2/Gro beta 7.86 49.2-11,960 1:2 1:2 1:2 27
CXCL4/PF4 21.1 356-86,540 1:2 1:4,000 1:200 56
CXCL5/ENA-78 8.2 50.2-12,200 1:2 1:2 1: 52
CXCL6/GCP-2 3.02 28.4-6,890 1:2 1:2 1:2 21
CXCL7/NAP-2 55.1 779-189,310 1:2 1:200 1:200 47
CXCL8/IL-8 1.8 4.4-1,060 1:2 1:2 1:2 18
CXCL9/MIG 18.4 450-109,310 1:2 1:2 1:2 52
CXCL10/IP-10 1.18 2.8-690 1:2 1:2 1:2 21
CXCL11/I-TAC 7.8 17.7-4,300 1:2 1:2 1:2 63
CXCL12/SDF-1 alpha 17.0 151-36,720 1:2 1:2 1:2 20
CXCL13/BLC/BCA-1 11.5 12.6-3,060 1:2 1:2 1:2 28
CXCL14/BRAK 26.0 97.1-236,00 1:2 1:2 1:2 66
CXCL16 0.386 10.1-2,460 1:2 1:2 1:2 39
Cystatin C 103 666-161,910 1:2 1:50 1:50 75
DcR3 55.9 472-114,610 1:2 1:2 1:2 54
Dkk-1 50.9 218-53,030 1:2 1:2 1:2 30
DPPIV/CD26 78.7 237-57,610 1:2 1:50 1:50 19
DR3/TNFRSF25 58.6 545-132,330 1:2 1:2 1:2 72
EGF 8.9 18.7-4,550 1:2 1:2 1:2 25
EMMPRIN 7.6 95.8-23,280 1:2 1:2 1:2 12
Endocan/ESM-1, NEW 1.08 11.7-2,850 1:2 1:2 1:2 22
Endoglin 68.0 326-79,210 1:2 1:2 1:2 22
Endostatin 27.3 153-37,200 1:2 1:2 1:2 74
Endothelin-1 1.31 11.6-2,810 1:2 1:2 1:2 76
Enolase 2/Neuron-specific Enolase 140 437-106,130 1:2 1:2 1:2 48
ENPP-2/Autotaxin 99.3 2,835-688,850 1:2 1:2 1:2 42
EN-RAGE/S100A12 1.77 28.4-6,900 1:2 1:50 1:50 53
EpCAM/TROP1 2.22 48.6-11,820 1:2 1:2 1:2 53
EphA2 176 339-82,340 1:2 1:2 1:2 52
ErbB2/Her2 36.6 144-34,900 1:2 1:2 1:2 75
ErbB3/Her3 9.42 1,485-360,810 1:2 1:2 1:2 54
ESAM 7.67 45.3-11,000 1:2 1:2 1:2 67
E-Selectin 18.8 318-77,320 1:2 1:2 1:2 45
FABP4/A-FABP 95.7 637-154,890 1:2 1:2 1:2 25
Fas 3.23 104-25,360 1:2 1:2 1:2 73
Fas Ligand 1.23 17-4,130 1:2 1:2 1:2 39
Ferritin 1.29 25.8-6,270 1:2 1:50 1:50 19
Fetuin A/AHSG 241 5,903-1,434,500 1:2 1:4,000 1:4,000 57
FGF acidic 4.88 8.9-2,170 1:2 1:2 1:2 67
FGF basic - NEW 6.5 1.89-460 1:2 1:2 1:2 47
FGF-13 1B 20.6 216-52,540 1:2 1:2 1:2 25
FGF-23 10.2 12.1-2,940 1:2 1:2 1:2 55
Fibroblast Activation Protein 0.667 22.6-5,480 1:2 1:50 1:50 20
Fibronectin 171 3,761-914,030 1:2 1:4,000 1:4,000 56
FLRG 52.0 962-233,660 1:2 1:2 1:2 29
Flt-3 Ligand 1.50 14.9-3,610 1:2 1:2 1:2 77
Follistatin-like 1 281 1,207-293,790 1:2 1:2 1:2 55
Galectin-1 632 1,548-376,270 1:2 1:2 1:2 51
Galectin-3 1.68 17.7-4,290 1:2 1:50 1:50 34
Galectin-3BP/MAC-2BP 194 830-201,700 1:2 1:50 1:50 76
Galectin-9 29.0 79.8-19,400 1:2 1:2 1:2 18
Gas6 3.58 109-26,560 1:2 1:50 1:50 48
G-CSF 4.1 21.5-5,230 1:2 1:2 1:2 54
GDF-15 1.2 34.2-8,320 1:2 1:2 1:2 65
GDNF 0.582 5.56-1,350 1:2 1:2 1:2 78
GITR 11.1 152-37,010 1:2 1:2 1:2 61
Glucagon 11.7 42.3-10,270 1:2 1:2 1:2 26
GM-CSF 4.1 12.5-3,030 1:2 1:2 1:2 46
gp130 11.2 371-90,180 1:2 1:2 1:2 13
Granzyme A 2.18 27.4-6,650 1:2 1:2 1:2 47
Granzyme B 1.42 17.7-4,300 1:2 1:2 1:2 57
Growth Hormone 12.2 75.8-18,430 1:2 1:2 1:2 44
HB-EGF 0.4 11.9-2,900 1:2 1:2 1:2 22
HE4/WFDC-2, 10.8 198-48,000 1:2 1:2 1:2 62
HGF 1.0 40.7-9,890 1:2 1:2 1:2 66
HGF R/c-MET 2.48 165-40,120 1:2 1:50 1:50 63
HTRA2/Omi 0.955 55.8-13,550 1:2 1:2 1:2 65
ICAM-1 87.9 6,615-1,607,350 1:2 1:2 1:2 61
IFN-beta 0.476 14.1-3,430 1:2 1:2 1:2 21
IFN-gamma 0.40 49.2-11,950 1:2 1:2 1:2 29
IFN-gamma R1 0.11 2.9-700 1:2 1:2 1:2 55
IGFBP-1 42.6 139-33,690 1:2 1:2 1:2 38
IGFBP-2 116 764-185,720 1:2 1:50 1:50 26
IGFBP-3 248 3,101-753,580 1:2 1:2 1:2 45
IGFBP-4 16.2 136-33,070 1:2 1:2 1:2 53
IGFBP-6 2.39 38.3-9,308 1:2 1:200 1:200 27
IGFBP-rp1/IGFBP-7 118 385-93,600 1:2 1:2 1:2 77
IL-1 alpha 0.9 5.02-1,220 1:2 1:2 1:2 38
IL-1 beta 0.8 16.3-3,960 1:2 1:2 1:2 28
IL-1 ra 18.0 27.5-6,690 1:2 1:2 1:2 30
IL-1 RI 4.49 119-28,940 1:2 1:2 1:2 63
IL-1 RII 18.0 275-66,710 1:2 1:2 1:2 62
IL-2 1.8 31.1-7,560 1:2 1:2 1:2 43
IL-2 R alpha/CD25 1.3 27-6,570 1:2 1:2 1:2 47
IL-3 11.6 84.5-20,530 1:2 1:2 1:2 15
IL-4 9.3 16.3-3,950 1:2 1:2 1:2 39
IL-4 R alpha 0.290 2.42-589 1:2 1:2 1:2 22
IL-5 0.5 5.84-1,420 1:2 1:2 1:2 53
IL-6 1.7 4.5-1,100 1:2 1:2 1:2 13
IL-6 R alpha 0.580 178-43,360 1:2 1:2 1:2 27
IL-7 0.410 4.5-1,100 1:2 1:2 1:2 29
IL-10 1.6 3.6-880 1:2 1:2 1:2 22
IL-11 24.7 516-125,410 1:2 1:2 1:2 72
IL-12/23 p40 35.2 383-93,100 1:2 1:2 1:2 67
IL-12 p70 20.2 127-30,920 1:2 1:2 1:2 56
IL-13 32.4 455-110,520 1:2 1:2 1:2 47
IL-15 1.01 6.3-1,540 1:2 1:2 1:2 63
IL-16 1.35 40.6-9,870 1:2 1:2 1:2 25
IL-17A 1.8 9.26-2,250 1:2 1:2 1:2 42
IL-17C 1.57 36.8-8,940 1:2 1:2 1:2 55
IL-17E/IL-25 27.7 369-89,590 1:2 1:2 1:2 30
IL-18 1.93 54.6-13,260 1:2 1:2 1:2 78
IL-18 BPa 1.9 99.3-24,120 1:2 1:2 1:2 15
IL-19 64.3 306-74,240 1:2 1:2 1:2 74
IL-21 0.869 29.4-7,140 1:2 1:2 1:2 65
IL-22 11.7 16.3-3,970 1:2 1:2 1:2 35
IL-23 11.4 229-55,600 1:2 1:2 1:2 76
IL-27 122 433-105,300 1:2 1:2 1:2 25
IL-28A/IFN-lambda 2 8.6 265-64,460 1:2 1:2 1:2 12
IL-28B/IFN-lambda 3 8.35 209-50,900 1:2 1:2 1:2 66
IL-31 9.72 46.3-11,260 1:2 1:2 1:2 36
IL-33 1.8 47.5-11,550 1:2 1:2 1:2 14
IL-34 18.7 164-39,950 1:2 1:2 1:2 43
IL-36 beta/IL-1F8 0.903 4.0-960 1:2 1:2 1:2 65
Total Inhibin 21.7 50.3-12,220 1:2 1:2 1:2 44
Insulin 9.91 37.9-9,220 1:2 1:2 1:2 14
Insulin C-Peptide 2.83 44.7-10,860 1:2 1:2 1:2 20
ITIH4 141 1,069-259,700 1:2 1:4,000 1:4,000 12
Kallikrein 3/PSA 8.30 73.9-17,950 1:2 1:2 1:2 26
Kallikrein 5 81.5 108-26,230 1:2 1:2 1:2 21
Kallikrein 6/ Neurosin 5.45 277-67,240 1:2 1:2 1:2 56
Lactoferrin 201 573-139,190 1:2 1:50 1:50 36
LBP 83.9 747-181,524 1:2 1:200 1:200 57
Leptin 10.2 493-119,830 1:2 1:2 1:2 51
Leptin R 283 4,182-1,016,310 1:2 1:2 1:2 42
LIF 9.31 26.9-6,530 1:2 1:2 1:2 33
LIGHT 0.691 11.4-2,770 1:2 1:2 1:2 30
Lipocalin-2/NGAL 29.2 140-33,920 1:2 1:50 1:50 53
L-Selectin 106 1,975-479,920 1:2 1:2 1:2 19
Lumican 497 9,458-2,298,400 1:2 1:50 1:50 13
LRG1 13.7 231-56,170 1:2 1:200 1:200 73
LT-alpha/TNF-beta 1.52 8.97-2,180 1:2 1:2 1:2 45
MAdCAM-1 51.3 1,074-260,896 1:2 1:2 1:2 33
MBL 1.78 44.2-10,730 1:2 1:4,000 1:4,000 61
MCAM/CD146 3.50 215-52,240 1:2 1:2 1:2 74
M-CSF 33.3 514-124,810 1:2 1:2 1:2 48
Mesothelin 22.9 802-194,860 1:2 1:2 1:2 62
MFG-E8 29.4 218-52,990 1:2 1:2 1:2 51
MIA 55.3 24.5-5,950 1:2 1:2 1:2 63
MICB 35.8 108-26,290 1:2 1:2 1:2 14
Midkine 6.64 42.8-10,410 1:2 1:2 1:2 64
MIF 38.8 354-86,080 1:2 1:2 1:2 21
MMP-1 2.7 33-8,020 1:2 1:2 1:2 19
MMP-2 108 296-71,930 1:2 1:50 1:50 20
MMP-3 5.3 81.5-19,810 1:2 1:2 1:2 15
MMP-7 23.2 346-84,090 1:2 1:2 1:2 21
MMP-8 34.2 454.5-110,440 1:2 1:2 1:2 27
MMP-9 13.6 133.6-32,460 1:2 1:50 1:50 14
MMP-10 1.3 53.7-13,050 1:2 1:2 1:2 66
MMP-12 7.1 40.8-9,910 1:2 1:2 1:2 34
MMP-13 19.0 138.7-33,700 1:2 1:2 1:2 33
MPO 20.4 142-34,500 1:2 1:50 1:50 53
MSP-MST1 26.9 103-25,000 1:2 1:200 1:200 14
NAGLU 7.68 398-96,700 1:2 1:2 1:2 34
N-Cadherin 55.1 1,015-246,650 1:2 1:50 1:50 39
NCAM-1 412 872-212,000 1:2 1:2 1:2 15
Nectin-4 17.2 81.5-19,810 1:2 1:2 1:2 28
Nephrin 22.2 390-94,800 1:2 1:2 1:2 12
Neuropilin-1 5.31 86.2-20,950 1:2 1:50 1:50 34
beta-NGF 0.259 3.95-960 1:2 1:2 1:2 28
NRG1-ß1/HRG1-ß1 4.63 35.9-8,720 1:2 1:2 1:2 54
NT-4 1.30 9.05-2,200 1:2 1:2 1:2 19
NT-Pro-ANP 66.2 271-65,820 1:2 1:2 1:2 35
Oncostatin M 44.3 406-98,700 1:2 1:2 1:2 30
Osteoactivin 31.4 880-213,800 1:2 1:2 1:2 43
Osteopontin 413 1,804-438,290 1:2 1:2 1:2 54
Osteoprotegerin 3.62 81.4-19,770 1:2 1:2 1:2 27
PARK5/UCH-L1 60.7 2,982-241,550 1:2 1:2 1:2 77
PARK7/DJ-1 49.1 279-67,880 1:2 1:2 1:2 37
PBEF/Visfatin 2,243 9,926-2,411,900 1:2 1:2 1:2 20
PDGF-AA 0.747 5.6-1,350 1:2 1:50 1:2 56
PDGF-AB 3.28 35.4-8,605 1:2 1:2 1:2 35
PDGF-BB 0.200 13.6-3,310 1:2 1:50 1:50 18
PDGF-CC 2.49 60.5-14,690 1:2 1:2 1:2 52
PDGF-DD 0.200 16.3-3,960 1:2 1:2 1:2 54
Pentraxin 2/SAP 1.66 75.8-18,410 1:2 1:40,000 1:40,000 45
Pentraxin 3/TSG-14 39.5 207-50,250 1:2 1:2 1:2 29
Periostin/OSF-2 80.9 1,242-301,720 1:2 1:2 1:2 55
PLA2G7/PAF-AH/Lp-PLA2 326 3,647-886,100 1:2 1:2 1:2 46
PlGF 3.9 1.9-470 1:2 1:2 1:2 72
PP14/Glycodelin 318 874-212,310 1:2 1:2 1:2 36
Procalcitonin 0.967 10.8-2,630 1:2 1:2 1:2 39
Progranulin 174 1,102-267,690 1:2 1:2 1:2 57
Prolactin 224 1,170-284,230 1:2 1:2 1:2 36
Properdin 148 2,330-566,160 1:2 1:200 1:200 67
Proprotein Convertase 9/ PCSK9 246 810-196,860 1:2 1:2 1:2 44
Protein S/PROS1 8.15 128-31,030 1:2 1:4,000 1:4,000 37
Proteinase 3/PRTN3 1.41 7.41-1,800 1:2 1:50 1:50 73
P-Selectin 9.0 199-48,330 1:2 1:2 1:2 48
RAGE 7.23 218-52,870 1:2 1:2 1:2 45
RBP4 231 564-136,970 1:2 1:4,000 1:4,000 61
Reg3A 3.71 253-61,550 1:2 1:2 1:2 53
Relaxin-2 6.72 69.1-16,790 1:2 1:2 1:2 56
Renin 21.1 189-45,900 1:2 1:2 1:2 61
Resistin 3.04 36.5-8,880 1:2 1:2 1:2 51
ROBO4 1.50 66.3-16,120 1:2 1:2 1:2 51
S100A9 6.39 26.9-6,530 1:2 1:2 1:2 46
S100A8 15.3 85.2-20,700 1:2 1:2 1:2 21
S100B 4.34 93.4-22,700 1:2 1:2 1:2 22
SCF 1.36 15.7-3,820 1:2 1:2 1:2 27
SCGF/CLEC11a 12.6 369-89,680 1:2 1:2 1:2 76
Serpin A7/TBG 28.4 775-188,420 1:2 1:200 1:200 61
Serpin A10/ZPI 20.8 955-232,088 1:2 1:200 1:200 73
Serpin A12/Vaspin 2.85 54.1-13,150 1:2 1:2 1:2 74
Serpin B3/SCCA1 17.6 81.0-19,690 1:2 1:2 1:2 75
Serpin C1/  Antithrombin-III 207 2,842-690,530 1:2 1:4,000 1:200 30
Serpin E1/PAI-1 0.670 19.5-4,730 1:2 1:200 1:200 43
Serpin F1/PEDF 3.66 143-34,793 1:2 1:4,000 1:4,000 38
SHBG 705 8,350-2,029,020 1:2 1:50 1:50 46
SLPI 31.4 732-177,950 1:2 1:2 1:2 77
SPARC 97.9 3,079-748,220 1:2 1:50 1:50 34
SP-D 21.3 256-62,120 1:2 1:2 1:2 62
ST2/IL-33 R 29.9 569-138,260 1:2 1:2 1:2 18
Syndecan-1/CD138 15.6 173-42,110 1:2 1:2 1:2 29
Syndecan-4 1.69 56.2-13,660 1:2 1:2 1:2 78
Synuclein-alpha 5.16 25.6-6,230 1:2 1:2 1:2 62
TACI 0.590 11.4-2,780 1:2 1:2 1:2 77
Tau 4.49 108-26,150 1:2 1:2 1:2 33
Tenascin C 6.58 33.3-8,100 1:2 1:2 1:2 35
TFF3 0.819 15.4-3,740 1:2 1:2 1:2 62
TFPI 33.1 336-81,740 1:2 1:2 1:2 64
TfR 67.5 395-95,990 1:2 1:200 1:200 13
TGF-alpha 0.820 18.6-4,510 1:2 1:2 1:2 63
Thrombomodulin 7.06 82.5-20,050 1:2 1:2 1:2 47
Thrombospondin-2 30.7 225-54,680 1:2 1:2 1:2 52
Thymidine Kinase 1/TK1 6.64 48.2-11,710 1:2 1:2 1:2 76
Tie-1 224 4,716-1,146,080 1:2 1:2 1:2 64
Tie-2 211 614-149,166 1:2 1:2 1:2 56
TIM-1/KIM-1/HAVCR 17.3 100-24,370 1:2 1:2 1:2 57
TIMP-1 3.42 54.7-13,280 1:2 1:50 1:50 76
TNF-alpha 1.2 20.7-2,160 1:2 1:2 1:2 12
TNF RI 41.0 221-53,820 1:2 1:2 1:2 66
TNF RII 0.450 3.9-950 1:2 1:2 1:2 65
Tpo 24.8 411-99,910 1:2 1:2 1:2 55
TRAIL 9.65 21.7-5,270 1:2 1:2 1:2 37
TRAIL R2/DR5 2.15 16.9-4,110 1:2 1:2 1:2 44
TRAIL R3 1.72 273-66,410 1:2 1:2 1:2 74
TRANCE/RANK L 4.68 11.9-2,890 1:2 1:2 1:2 48
TREM-1 10.7 115-28,060 1:2 1:2 1:2 65
TSLP 0.432 2.92-710 1:2 1:2 1:2 48
ULBP-1 6.41 48.5-11,790 1:2 1:2 1:2 18
ULBP-2/5/6 62.3 168-40,870 1:2 1:2 1:2 20
ULBP-3 8.42 166-40,390 1:2 1:2 1:2 22
ULBP-4/RAET1E 26.0 64.4-15,650 1:2 1:2 1:2 26
uPA/Urokinase 23.5 133-32,200 1:2 1:2 1:2 78
uPAR 43.2 182-44,260 1:2 1:2 1:2 19
Uromodulin 36.6 777-188,770 1:2 1:50 1:50 64
Uteroglobin 3.98 31.5-7,650 1:2 1:50 1:50 65
VAP-1 5.37 86.5-21,010 1:2 1:50 1:50 42
VCAM-1 238 8,317-2,021,050 1:2 1:2 1:2 57
VEGF-A 2.1 8.5-2,070 1:2 1:2 1:2 26
VEGF-C 5.46 57.0-13,860 1:2 1:2 1:2 38
VEGF-D 11.1 53-12,890 1:2 1:2 1:2 73
VEGF R1 5.68 72.1-17,530 1:2 1:2 1:2 38
VEGF R2/KDR 7.4 154-37,400 1:2 1:2 1:2 12
VEGF R3 2.71 68.8-16,710 1:2 1:2 1:2 57
Vitamin D Binding Protein 227 6,655-1,617,080 1:2 1:50 1:50 38
vWF-A2 11.9 44.2-10,740 1:2 1:2 1:2 15
XCL1/Lymphotactin 53.0 90.5-7,330 1:2 1:2 1:2 39

*A standard curve must be generated each time an assay is run, utilizing values from the Certificate of Analysis provided with each Luminex Assay.

 

Assays for the Luminex platform are offered as High Performance Assays or Assays. The Luminex High Performance Assays are fully validated panels with a focused selection of analytes. They are available in We Mix, You Mix, and Predetermined formats. The Luminex Assays allows for the maximum number of analytes in a multiplex and is supplied as a premixed kit. View a table comparing the features and benefits of these bead-based multiplex assays.

Trademarks and registered trademarks are the property of their respective company.

Citations:

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

17 Citations: Showing 1 - 10
Filter your results:

Species
Sample Type
  1. Immune adaptation to chronic intense exercise training: new microarray evidence
    Authors: D Liu, R Wang, AR Grant, J Zhang, PM Gordon, Y Wei, P Chen
    BMC Genomics, 2017;18(1):29.
    Species: Human
    Sample Type: Serum
  2. Bilirubin Prevents Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor-Deficient Mice by Inhibiting Endothelial VCAM-1 and ICAM-1 Signaling
    Authors: ME Vogel, G Idelman, ES Konaniah, SD Zucker
    J Am Heart Assoc, 2017;6(4):.
    Species: Human
    Sample Type: Cell Culture Supernates
  3. Aberrant SYK kinase signaling is essential for tumorigenesis induced by TSC2 inactivation
    Authors: Y Cui, WK Steagall, A Lamattina, G Pacheco-Ro, M Stylianou, P Kidambi, B Stump, F Golzarri, IO Rosas, C Priolo, EP Henske, J Moss, S El-Chemaly
    Cancer Res, 2017;0(0):.
    Species: Human
    Sample Type: Serum
  4. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA)
    Authors: A Futakuchi, T Inoue, T Fujimoto, U Kuroda, M Inoue-Moch, E Takahashi, S Ohira, H Tanihara
    Invest. Ophthalmol. Vis. Sci., 2017;58(4):2421-2429.
    Species: Human
    Sample Type: Cell Culture Supernates
  5. Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate's plasma levels of some cytokines known to regulate T cells differentiation and function
    Malar. J., 2016;15(1):561.
    Species: Human
    Sample Type: Plasma
  6. Assessment of the Role of Metabolic Determinants on the Relationship between Insulin Sensitivity and Secretion
    PLoS ONE, 2016;11(12):e0168352.
    Species: Human
    Sample Type: Plasma
  7. Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis
    Sci Rep, 2016;6(0):33951.
    Species: Human
    Sample Type: Plasma
  8. Data on serologic inflammatory biomarkers assessed using multiplex assays and host characteristics in the Multicenter AIDS Cohort Study (MACS)
    Data Brief, 2016;9(0):262-70.
    Species: Human
    Sample Type: Serum
  9. CF Lung Infection and Inflammation: IL-17 Pathophysiology and Therapeutic Intervention
    Authors: Daniel Hsu
    Infect Immun, 2016;0(0):.
    Species: Human
    Sample Type: Cell Culture Supernates
  10. In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab
    Br J Cancer, 2016;114(11):1212-8.
    Species: Human
    Sample Type: Plasma
  11. T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions
    PLoS ONE, 2016;11(7):e0160291.
    Species: Human
    Sample Type: Cell Culture Supernates
  12. Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection
    Authors: Kuan-Ting Liu
    Int J Mol Sci, 2016;17(6):.
    Species: Human
    Sample Type: Serum
  13. Levels of Adipokines in Amniotic Fluid and Cord Blood Collected from Dichorionic-Diamniotic Twins Discordant for Fetal Growth
    PLoS ONE, 2016;11(5):e0154537.
    Species: Human
    Sample Type: Amniotic Fluid
  14. Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
    Authors: KA Thibert, GV Raymond, J Tolar, WP Miller, PJ Orchard, TC Lund
    Sci Rep, 2016;6(0):24579.
    Species: Human
    Sample Type: CSF
  15. Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice.
    Authors: Karkeni E, Marcotorchino J, Tourniaire F, Astier J, Peiretti F, Darmon P, Landrier J
    Endocrinology, 2015;156(5):1782-93.
    Species: Human
    Sample Type: Cell Culture Supernates
  16. The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling.
    Authors: Fleming B, Chandrasekaran P, Dillon L, Dalby E, Suresh R, Sarkar A, El-Sayed N, Mosser D
    J Leukoc Biol, 2015;98(3):395-407.
    Species: Human
    Sample Type: Cell Culture Supernates
  17. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.
    Authors: Butterfield L, Economou J, Gamblin T, Geller D
    J Transl Med, 2014;12(0):86.
    Species: Human
    Sample Type: Serum
Expand to show all 17 Citations
Average Rating: 4 (Based on 2 reviews)

Have you used Human Magnetic Luminex Assay?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Read what people are saying who have used Human Magnetic Luminex Assay.

Filter by Ratings
Very Good
(2)
All Ratings
Filter by Applications
All Applications
Filter by Species
All Species

Images Ratings Applications Species Reviewed By Date Details
 Human Magnetic Luminex Screening Assay LXSAHM
Enlarge
Very Good
  Anonymous 06/14/2016
Show
Image Details
 Human Magnetic Luminex Screening Assay LXSAHM
: Human Magnetic Luminex Screening Assay [LXSAHM]

Summary

Sample TestedTissue Culture Media
 Human Magnetic Luminex Screening Assay LXSAHM
Enlarge
Very Good
  Anonymous 06/13/2016
Show
Image Details
 Human Magnetic Luminex Screening Assay LXSAHM
: Human Magnetic Luminex Screening Assay [LXSAHM]

Summary

Sample TestedTissue Culture Media

FAQs

  1. What is the difference between the Luminex® Screening Assay and the Luminex® Performance Assay?

    • In general, the sensitivity of Luminex® Screening Assays and Luminex® Performance Assays is similar. A Performance Assay consists of select analytes which have been thoroughly tested and validated together as a panel. The diluents provided in the performance kits and assay conditions have been optimized for best results with the analytes on the same panel. The Performance Assay is the most precise, reproducible and accurate Luminex tool offered by R&D Systems.

      The Screening Assay option is a flexible tool, providing the uncommon opportunity to customize by mixing and matching analytes across different panels. Although not as extensively tested as the Performance Assays, analytes on a Screening Assay are tested together when built and a final quality control test on each Screening Assay is performed prior to release. Since each Screening Assay is unique and built-to-order, additional days are required for order fulfillment and it is not characterized by the same level of optimization and validation testing as with the Performance assays.  

      For low abundance cytokines, High Sensitivity panels are available for Performance Assay, which are not available for Screening Assay. 

      The quality of the R&D Systems® Screening Assays is similar to the Luminex® Assays offered by other vendors. The following chart compares the different types of Luminex® Assays R&D Systems offers and may serve as a general guide for choosing which assay format is suitable to your experimental goals. 

      https://www.rndsystems.com/products/which-luminex-assay-right-me

       

View all Luminex Assay FAQs

Order Details

Size Price Stk
LXSAHM
1 Kit
Build Now

Build your own with our Luminex Assay Customization Tool.

Contact Information

R&D Systems Guarantee

Feedback

Customer Information